BioLineRx Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Go back to BioLineRx Reports Second Quarter 2022 Financial Results and Provides Corporate Update

BioLineRx (BLRX) Tops Q2 EPS by 12c

August 16, 2022 8:07 AM EDT

BioLineRx (NASDAQ: BLRX) reported Q2 EPS of ($0.01), $0.12 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

... More